Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "NOVARTIS"
showing the first 40- LECTEC CORP /MN/ (AXGN)10-Q · 2002-08-14Read the filing on SEC.gov →
- NOVARTIS AG424B3 · 2011-02-28Read the filing on SEC.gov →
- Vanda Pharmaceuticals Inc. (VNDA)S-1/A · 2006-04-07Read the filing on SEC.gov →
- NOVARTIS AG6-K · 2016-05-17Read the filing on SEC.gov →
- Enumeral Biomedical Holdings, Inc.8-K/A · 2014-10-31Read the filing on SEC.gov →
- Ophthotech Corp.10-Q · 2014-08-06Read the filing on SEC.gov →
- CHIRON CORPSC 13D/A · 2005-11-01Read the filing on SEC.gov →
- IDENIX PHARMACEUTICALS INC10-Q · 2012-08-08Read the filing on SEC.gov →
- IDENIX PHARMACEUTICALS INCSC 13D/A · 2012-08-10Read the filing on SEC.gov →
- BMP Sunstone CORP10-K/A · 2009-01-23Read the filing on SEC.gov →
- EMISPHERE TECHNOLOGIES INCSC 13D/A · 2010-06-09Read the filing on SEC.gov →
- IONIS PHARMACEUTICALS INC (IONS)10-Q · 2017-05-09Read the filing on SEC.gov →
- ALCON INC (ALC)6-K · 2011-03-01Read the filing on SEC.gov →
- UNIGENE LABORATORIES INC10-Q/A · 2008-03-20Read the filing on SEC.gov →
- DISCOVERY PARTNERS INTERNATIONAL INC (INFIQ)S-4/A · 2006-08-07Read the filing on SEC.gov →
- Olema Pharmaceuticals, Inc. (OLMA)DRS · 2020-09-21Read the filing on SEC.gov →
- CODEXIS, INC. (CDXS)10-Q · 2019-08-06Read the filing on SEC.gov →
- CELGENE CORP /DE/10-K · 2001-03-21Read the filing on SEC.gov →
- NOVARTIS AG425 · 2010-12-15Read the filing on SEC.gov →
- Foundation Medicine, Inc.S-1/A · 2013-08-27Read the filing on SEC.gov →
- AVANIR PHARMACEUTICALS10-Q · 2005-08-15Read the filing on SEC.gov →
- CIMA LABS INC10-Q · 2001-11-14Read the filing on SEC.gov →
- Reliant Pharmaceuticals, Inc.S-1 · 2007-08-10Read the filing on SEC.gov →
- Reliant Pharmaceuticals, Inc.S-1/A · 2005-08-05Read the filing on SEC.gov →
- ALCON INC (ALC)20FR12B/A · 2019-01-18Read the filing on SEC.gov →
- ALCON INC (ALC)6-K · 2010-12-16Read the filing on SEC.gov →
- Reliant Pharmaceuticals, Inc.S-1/A · 2005-06-06Read the filing on SEC.gov →
- NOVARTIS AGF-4/A · 2011-02-17Read the filing on SEC.gov →
- COMBINATORX, INC10-Q · 2009-05-11Read the filing on SEC.gov →
- Vanda Pharmaceuticals Inc. (VNDA)S-1/A · 2006-02-16Read the filing on SEC.gov →
- ALCON INC (ALC)6-K · 2010-12-16Read the filing on SEC.gov →
- QUESTCOR PHARMACEUTICALS INC10-Q · 2013-07-31Read the filing on SEC.gov →
- NOVARTIS AGF-4/A · 2011-02-24Read the filing on SEC.gov →
- QUARK PHARMACEUTICALS INCS-1/A · 2010-11-24Read the filing on SEC.gov →
- CELGENE CORP /DE/10-K · 2001-03-21Read the filing on SEC.gov →
- LECTEC CORP /MN/ (AXGN)10QSB · 2004-08-16Read the filing on SEC.gov →
- NOVARTIS AGSC 13D/A · 2010-12-15Read the filing on SEC.gov →
- NOVARTIS AGF-4/A · 2011-02-02Read the filing on SEC.gov →
- ALCON INC (ALC)20FR12B/A · 2019-03-13Read the filing on SEC.gov →
- Monte Rosa Therapeutics, Inc. (GLUE)10-Q · 2025-11-06Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.